MRI for early detection of breast cancer spread
Part of Cancer, Skin clinical trials.
This trial is testing a new way to use MRI scans to find breast cancer that has spread to other parts of the body early. It is for people who have had aggressive breast cancer (HER2 positive or triple negative) and finished treatment with surgery, but still have a higher risk of the cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had breast cancer that was stage II or III and was either HER2 positive or triple negative.
- You had surgery, and if you had chemotherapy before surgery, some cancer was still found after surgery.
- Your staging scans around the time of surgery showed no signs of cancer spreading to other organs.
- You are 75 years old or younger.
- You are in good general health (able to do daily activities without needing help) and have no other active cancers.
- You are willing and able to travel to the study center for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether taking screening brain MRI scans in people with stage IV breast cancer helps find brain involvement earlier. It may help guide treatment decisions for those who would otherwise only get brain imaging after symptoms start.
This trial studies whether a special MRI scan can better predict whether early cervical cancer has spread into tiny lymph and blood vessels (lymphovascular space invasion) before surgery. If it works, it may help doctors plan the best treatment after surgery.
This study tests advanced MRI imaging techniques to better diagnose breast cancer and evaluate treatment response. If you have a suspicious breast lesion, this trial may help doctors see it more clearly before biopsy or surgery.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This study uses a breast MRI scan to look at suspicious areas in the breast. It may help doctors better tell which breast changes need closer follow-up like a biopsy.
Hear when a new HER2-positive Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.